Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | N/A | N/A | N/A | N/A | 9 |
| Operating Expenses | 160 | 286 | 260 | 271 | 219 |
| Operating Income | -160 | -286 | -260 | -271 | -210 |
| Other Income | 160 | 286 | 260 | 271 | 210 |
| Net Income Continuous | -157 | -280 | -256 | -264 | -210 |
| Net Income | $-157 | $-280 | $-256 | $-264 | $-210 |
| EPS Basic Total Ops | -0.04 | -0.22 | -0.09 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.04 | -0.22 | -0.09 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.04 | -0.22 | -0.09 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.04 | -0.22 | -0.09 | -0.09 | -0.09 |
| EBITDA(a) | $-150 | $-270 | $-255 | $-259 | $-203 |